Small biotech company Halozyme is behind some of the biggest names in medicine, including Johnson & Johnson's Darzalex and Roche's Tecentriq.
With the technology sector taking over in 2024, now is a great time to consider the best breakout biotech stocks to buy. Investing in these companies can be risky yet extremely rewarding, with careful selection of industry leaders. Investors often seek outsized returns in the biotechnology sector through small-cap, early-stage companies. However, many mid and large-cap biotech companies have incredible pipelines, impressive financial performance, and long-term growth opportunities. When looking
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.